Skip to Main Content
Services Talent Knowledge
Site Search
Menu

News

August 27, 2020

Linda Clark Published in America's Pharmacist

Linda Clark, Health Care Controversies Team leader, recently had her “A Tale of Two Courts: How Opioid Cases, Evolving During the COVID-19 Crisis, May Shape Pharmacist Liability and Best Practices” article published in the National Community Pharmacists Association’s America’s Pharmacist.

“Even as the world’s health care system faces the unprecedented challenges of the COVID-19 pandemic, opioid litigation continues its march through the legal system toward trial (Figure 1). These cases against drug companies, suppliers, and pharmacies are expected to yield important precedent that may broadly affect pharmacist liability and practices in the emerging post-COVID world.

The lawsuits have been filed by many different plaintiffs, including cities, counties, Native American tribes, and municipalities. More than 2,500 federal lawsuits have been brought against participants in the drug supply chain including pharmaceutical manufacturers, distributors, and retailers. The claims asserted seek reimbursement for governmental expenditures arising out of opioid addictions and overdoses. The defendants have included major pharmaceutical companies such as McKesson Corp., Cardinal Health, AmerisourceBergen, Purdue Pharma, Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), Endo International, Teva Pharmaceutical, Allergan (formerly Actavis), Watson Pharmaceuticals, and Covidien. Many of these cases have been consolidated into a combined case often referred to as the “MDL” or “Multidistrict Opioid Litigation” now pending before a US District Court in Cleveland, Ohio.”

Read the full article here.

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

SCOTUS Strikes Down OSHA Vaccinate-or-Test Rule, but Allows CMS Mandate to Proceed

Alerts

New York State Appellate Court Grants Insurer's Motion to Rescind Policy Based on Misrepresentation in Application

Alerts

Late Fees After Acceleration or Maturity

Alerts

New York State Quietly Diverts $1.6 Billion in Federal Pandemic Funds to a Small Group of Large Home Care Providers

Alerts

Standards for Emerging Contaminants Among Proposed Changes to NYS Department of Environmental Conservation's Site Cleanup Programs

Alerts

New York Creates New Framework for Regulating PBMs: What Does It Mean for Pharmacies and Consumers?

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out